Navigation Links
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
Date:2/21/2008

s royalties from GSK on worldwide 3TC sales. GSK's worldwide sales of 3TC for the year to December 31, 2007 were $1,110 million, a decrease of 2% compared to the same period in 2006 (2006: $1,138 million), but a decrease of approximately 7% on a constant exchange rate basis. While the nucleoside analogue market for HIV has continued to grow, competitive pressures within the market have increased leading to a decline in 3TC sales.

In 2007 generic drug companies filed Abbreviated New Drug Applications ("ANDA") seeking approval for EPIVIR, COMBIVIR, ZEFFIX and EPZICOM in the US. Pursuant to the GSK/Shire license for lamivudine products, GSK has the right to enforce the licensed patents. In November 2007 GSK filed a patent infringement lawsuit against Teva Pharmaceuticals, Inc. (Teva) in the US District Court for the District of Delaware for infringement of one of the patents relating to COMBIVIR. The patent, which covers the combination of AZT and lamivudine to treat HIV, expires in May 2012. Teva had filed an ANDA with the FDA with a certification of invalidity, unenforceability and non-infringement of that combination patent. Teva did not challenge two other patents relating to COMBIVIR that expire in 2010 and 2016. The case is in its early stages.

ZEFFIX - Chronic hepatitis B infection

Royalties from sales of ZEFFIX for the year to December 31, 2007 were $41.0 million, an increase of 18% compared to the same period in 2006 (2006: $34.8 million). The impact of foreign exchange movements has contributed 8% to the reported growth; excluding favorable foreign exchange movements there has been an increase of 10% compared to the same period in 2006.

Shire receives royalties from GSK on worldwide ZEFFIX sales. GSK's worldwide sales of ZEFFIX for the year to December 31, 2007 were $341 million, an increase of 13% compared to the same period in 2006 (2006: $301 million). This increase was mainly due to strong growth in the Chinese market and favor
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Correction Re Website
2. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
3. Shire Engages Palio
4. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
5. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
6. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire plc: Board Changes
9. David Mott Appointed Non Executive Director at Shire
10. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
11. Shire Divests Non-Core Product Portfolio to Almirall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/gxqhg9/gene_therapy ) ... report "Gene Therapy - Technologies, Markets and ... Gene therapy technologies are described in detail ... with genetically modified vectors. Gene therapy is an ... of administration as well as targeted gene therapy ...
(Date:3/3/2015)... 3, 2015  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... a focus on protecting the microbiome, announced today that ... at the 27th Annual ROTH Conference being held on March ... in Dana Point, CA. Mr. ... at 1:00 p.m. (Pacific Time). A live webcast ...
(Date:3/3/2015)... , March 2, 2015  Phillip Sharp, Institute Professor at ... of the Department of Biology and the Koch Institute for Integrative ... at Heritage Day , May 14, at the ... the Othmer Gold Medal since it was first awarded ... "In 1977 Phil Sharp gave the scientific world ...
(Date:3/2/2015)... 02, 2015 Resilinc released ... report which summarizes and analyzes nearly 700 unique ... EventWatch™ 24X7 global event monitoring and alert reporting ... a free trial period of the email service to ... that can negatively impact revenue, market share, customer satisfaction, ...
Breaking Biology Technology:Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Synthetic Biologics to Present at the 27th Annual ROTH Conference 2Phillip Sharp to Receive 2015 Othmer Gold Medal 2Phillip Sharp to Receive 2015 Othmer Gold Medal 3Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 2Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 3
... Bay, Wis. - Whenever the title executive vice president ... an established part of management. So it is with Judy ... National following a career that she thought was winding ... Green Bay-based provider of global transportation, logistics, and intermodal services, ...
... students are no longer interested in technology careers? , ... Area Technical College has won first place in ... beating four teams from Minnesota, and later advanced to ... third place. , ,The competitions were open to students ...
... a series of articles on raising capital from investors. This installment ... the time when raising equity capital, the offering terms are summarized ... When dealing with angel investors , it is typical ... prospective angel investors will want to negotiate the initial term sheet, ...
Cached Biology Technology:CIO Leadership Series: Judy Lemke, Schneider National 2CIO Leadership Series: Judy Lemke, Schneider National 3CIO Leadership Series: Judy Lemke, Schneider National 4CIO Leadership Series: Judy Lemke, Schneider National 5Capital-raising term sheets for angels and venture capitalists 2Capital-raising term sheets for angels and venture capitalists 3Capital-raising term sheets for angels and venture capitalists 4Capital-raising term sheets for angels and venture capitalists 5
(Date:2/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/sxwl43/global_2d_gesture ... "Global 2D Gesture Recognition Market 2015-2019" report ... forecast the Global 2D Gesture Recognition market to ... period 2014-2019 The increased demand for ... of the major trends in the market. The ...
(Date:2/19/2015)... .19, 2015 Research and Markets ... the "Military Electro-Optical / Infrared Systems Market ... Platform - Forecast to 2020" report to ... systems market is expected to reach $16.35 billion ... This report segments the military electro-optical/infrared ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... Dates in Press Release, TAMPA, Fla., Feb. ... a leader in electro-stun technologies announced,today that as ... Taser International (Nasdaq: TASR ) has noticed ... Systems, Inc. (Federal Case,CV07-0042-PHX-MHM) of Taser,s intent to ...
... interested in natural history but it also challenges those people ... life on Earth. Thats the view of Dr Robert Lambert, ... of Nottingham, who has just returned from the Antarctic in ... Antarctica Tour Operators (IAATO). Dr Lambert, who is a ...
... University of Missouri scientist Ray Semlitsch studies creatures most ... at night and thrive in the shallow, cool, wet ... A collaborative study, with MU graduate student Bill Peterman, ... biomass (total mass of an organism in an area) ...
Cached Biology News:Taser Notices Intent to Serve Subpoena for Information on Old NIJ Tests in Taser v. Stinger 2Taser Notices Intent to Serve Subpoena for Information on Old NIJ Tests in Taser v. Stinger 3Observing sustainable tourism in Antarctica 2Observing sustainable tourism in Antarctica 3Salamanders, headwater streams critical in food chain 2